Skip to main navigation Skip to search Skip to main content

Sonochemically prepared BSA microspheres containing Gemcitabine, and their potential application in renal cancer therapeutics

  • Olga Grinberg
  • , Aharon Gedanken
  • , Chitta Ranjan Patra
  • , Sujata Patra
  • , Priyabrata Mukherjee
  • , Debabrata Mukhopadhyay
  • Nanotechnology Research Center
  • Mayo Clinic College of Medicine and Science

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Abstract

This report demonstrates the formation and characterization of sonochemically prepared bovine serum albumin (BSA)-Gemzar (Gemcitabine) microspheres and shows their increased anticancer activity compared to pristine Gemzar. The amount of loaded Gemzar was determined by light absorption measurements. The BSA-Gemzar composite was analyzed and characterized by optical microscopy and scanning electron microscopy. The release kinetics of Gemzar from the proteinaceous microspheres was tested. The BSA-Gemzar composite was examined for its anticancer activity (in vitro) in renal cancer cells (RCC, 786-O cells) using [3H]thymidine incorporation assays. It was found that the influence of the Gemzar-loaded microspheres on the cancer cells was significantly greater than that of an equimolar concentration of pristine Gemzar.

Original languageEnglish
Pages (from-to)3031-3037
Number of pages7
JournalActa Biomaterialia
Volume5
Issue number8
DOIs
StatePublished - Oct 2009
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • BSA microspheres
  • Drug delivery
  • Gemcitabine
  • Renal cancer 786-O cells
  • Sonochemistry

Fingerprint

Dive into the research topics of 'Sonochemically prepared BSA microspheres containing Gemcitabine, and their potential application in renal cancer therapeutics'. Together they form a unique fingerprint.

Cite this